Budget Impact Tool to Help Estimate Costs of Providing Medications to Treat Opioid Use Disorder in Jails/Prisons

Register for the webinar Despite the evidence that providing medications for opioid use disorder (MOUD; i.e., methadone, buprenorphine, and naltrexone) at the point of incarceration and during reentry reduce the risk of overdose death, decrease recidivism rates, and improve the well-being of the individual, financial and administrative limitations in jail/prison healthcare often serve as barriers…

Read More

HHS Releases New Medicaid Reentry 1115 Demonstration Opportunity to Increase Access to Care for Individuals Leaving Prison and Jail

On April 17, 2023, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), released new guidance that allows states to utilize Medicaid funds to provide health care services to incarcerated individuals, including substance use disorder treatment. The new Medicaid Reentry Section 1115 Demonstration Opportunity would provide states…

Read More

Latent class analysis of medical mistrust and COVID-19 vaccine hesitancy among adults in the United States just prior to FDA emergency use authorization

We used survey responses to conduct a latent class analysis to classify respondents into categories and explained this classification as a function of sociodemographic and attitudinal variables using multinomial logistic regression models. We then estimated the probability of respondents agreeing to receive a COVID-19 vaccine conditional on their medical mistrust category.

Read More